Table 2.
|
Abnormal cognitive test results |
Statistic |
p value |
Significant post-hoc differences |
||
---|---|---|---|---|---|---|
|
0 |
1 |
2 |
|
|
|
n = 55 | n = 68 | n = 77 | ||||
Ischemic heart disease |
43% |
34% |
27% |
χ2(2, N = 200) = 3.05 |
0.22 |
- |
Arrhythmia |
39% |
37% |
30% |
χ2(2, N = 200) = 1.45 |
0.49 |
- |
Heart failure |
24% |
30% |
29% |
χ2(2, N = 200) = 0.81 |
0.67 |
- |
Hypertension |
47% |
52% |
47% |
χ2(2, N = 200) = 0.37 |
0.83 |
- |
COPD |
26% |
19% |
16% |
χ2(2, N = 200) = 2.00 |
0.37 |
- |
Gastrointestinal disease |
22% |
18% |
13% |
χ2(2, N = 200) = 1.80 |
0.41 |
- |
Stroke/TIA |
19% |
21% |
21% |
χ2(2, N = 200) = 0.16 |
0.92 |
- |
Diabetes |
22% |
29% |
18% |
χ2(2, N = 200) = 2.63 |
0.27 |
- |
Cancer, nonskin |
31% |
30% |
25% |
χ2(2, N = 200) = 0.72 |
0.70 |
- |
Neurocognitive disorder |
6% |
4% |
12% |
χ2(2, N = 200) = 3.21 |
0.22 |
- |
Drugs in chart, mean(SD) |
7.1(3.8) |
7.6(4.0) |
6.6(3.7) |
F(2, 197) = 1.20 |
0.30 |
- |
Charlson comorbidity index, mean(SD) | 2.3(1.7) | 2.4(1.4) | 2.1(1.5) | F(2, 197) = 0.77 | 0.47 | - |
Past medical history of the three groups. TIA = transient ischemic attack. COPD = chronic obstructive pulmonary disorder.